Poplar Therapeutics

Poplar Therapeutics is a biotech company in Boston, United States, founded in 2024. It has raised $95.0M across 2 rounds, most recently a $45.0M Extension Round in March 2026.

Homepage

Employees
1–10
Founded
2024
Total Funding
$95.0M
Last Round
$45.0M Extension RoundMar 2026
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 6 investors for this company. The full record is or through the API.

About

Poplar Therapeutics is a clinical-stage immunology company developing a new class of anti-IgE therapy to challenge convention in allergic disease treatment. The company is on a mission to create the next generation of anti-IgE medicines so that patients can live free of fear. Its lead program, PHB-050, is a new class of anti-IgE therapy for multiple atopic conditions.

Summary

It lists 1–10 employees. It has raised $95.0M in total across 2 rounds, most recently a $45.0M Extension Round in Mar 2026. Investors include SR One, Vida Ventures and Janus Henderson Investors.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Extension RoundExtension RoundMar 2026
$45.0M

Sign up to see all 2 events

Funding: Series A through Extension Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Poplar Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/poplar-therapeutics"><img src="https://indexed.vc/api/badge/company/poplar-therapeutics" alt="Poplar Therapeutics on Indexed.vc" width="260" height="76" /></a>